{
    "id": 3649,
    "fullName": "DDR2 G505S",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "DDR2 G505S lies within the cytoplasmic domain of the Ddr2 protein (UniProt.org). G505S is transforming in cell culture (PMID: 22328973), and therefore, is predicted to result in a gain of Ddr2 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4921,
        "geneSymbol": "DDR2",
        "terms": [
            "DDR2",
            "MIG20a",
            "NTRKR3",
            "TKT",
            "TYRO10",
            "WRCN"
        ]
    },
    "variant": "G505S",
    "createDate": "03/10/2015",
    "updateDate": "07/24/2019",
    "referenceTranscriptCoordinates": {
        "id": 147355,
        "transcript": "NM_001014796",
        "gDna": "chr1:g.162772032G>A",
        "cDna": "c.1513G>A",
        "protein": "p.G505S",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5100,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sprycel (dasatinib) inhibited growth of transformed cells expressing DDR2 G505S in culture (PMID: 22328973).",
            "molecularProfile": {
                "id": 3450,
                "profileName": "DDR2 G505S"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5105,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited growth of transformed cells expressing DDR2 G505S in culture (PMID: 22328973).",
            "molecularProfile": {
                "id": 3450,
                "profileName": "DDR2 G505S"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5123,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Saracatinib (AZD0530) and Tasigna (nilotinib) reduced proliferation of transformed cells expressing DDR2 G505S in culture, with increased potency over either agent alone (PMID: 22328973).",
            "molecularProfile": {
                "id": 3450,
                "profileName": "DDR2 G505S"
            },
            "therapy": {
                "id": 3756,
                "therapyName": "Nilotinib + Saracatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3450,
            "profileName": "DDR2 G505S",
            "profileTreatmentApproaches": [
                {
                    "id": 19639,
                    "name": "DDR2 inhibitor",
                    "profileName": "DDR2 G505S"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 147353,
            "transcript": "XM_011509586",
            "gDna": "chr1:g.162772032G>A",
            "cDna": "c.1513G>A",
            "protein": "p.G505S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147356,
            "transcript": "NM_006182",
            "gDna": "chr1:g.162772032G>A",
            "cDna": "c.1513G>A",
            "protein": "p.G505S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147354,
            "transcript": "XM_011509587",
            "gDna": "chr1:g.162772032G>A",
            "cDna": "c.1513G>A",
            "protein": "p.G505S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147355,
            "transcript": "NM_001014796",
            "gDna": "chr1:g.162772032G>A",
            "cDna": "c.1513G>A",
            "protein": "p.G505S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147352,
            "transcript": "XM_006711344",
            "gDna": "chr1:g.162772032G>A",
            "cDna": "c.1513G>A",
            "protein": "p.G505S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}